Biohaven’s BHV-1200 A Multimodal Antibody Therapy Enhancer (MATE) Demonstrates Effective Neutralization Of Multiple Strains Of COVID-19

Vlad Coric M.D., Chief Executive Officer of Biohaven commented, “The battle against COVID-19 like the virus itselfis dynamic and ever changing. Prophylactic and therapeutic agents with broad specific… [read more]